October 23

 This schedule is provisional, and will be filled in as speakers and themes are confirmed. Be sure to return to this page regularly to stay up to date with the program.

09:00 – 10:35	SESSION 1: Transcriptomics, Genomics and Epigenetics
	Chair: Zhihong Liu, China
09:00 – 09:30	Keynote Lecture
	Transcriptomic imaging
	Joakim Lundeberg, Sweden
09:30 - 09:55	A million genomes and the Beijing Genome Institute (BGI)
	Jun Wang, China
09:55 - 10:20	Epigenetics and diabetic kidney disease
	Alexander Maxwell, UK
10:20 - 10:35	Oral Presentation from Abstract: DNA METHYLATION SEQUENCING IDENTIFIES CTCF REGULATED GENES IMPLICATED IN DIABETIC COMPLICATIONS
	Assam El Osta, Australia
10:35 – 11:05	Coffee Break & Poster Viewing
11:05 – 12:50	SESSION 2: Innate and Adaptive Immunity, and Renal Pathophysiology
	Chair: Alan Salama, UK
11:05 - 11:30	Innate lymphoid cells – New players in tissue injury and repair
	Jan-Eric Turner, Germany
11:30 - 11:55	Interaction of the Innate and Cognate immune system in Nephritis
	Stephen Alexander, Australia
11:55 – 12:20	The diverse function of macrophages in renal disease
	Jeremy Hughes, UK
12:20 – 12:35	Oral Presentation from Abstract Submissions
12:35 – 12:50	Oral Presentation from Abstract Submissions
12:50 - 14:00	Networking Lunch & Poster Viewing
14:00– 15:50	SESSION 3: Immunology and Metabolism - Immuno-Metabolism, an Emerging Frontier
	Chair: Ming-hui Zhao, China
14:00 - 14:30	Keynote Lecture
	Modulating mTOR activity to control T cell function
	Hans Stauss, UK
14:30 - 14:55	AMPK: linking inflammation and metabolism
	Morgan Fullerton, Canada
14:55 - 15:20	Prostaglandin (PG) E2 in the regulation of immunity and inflammation
	Youfei Guan, China
15:20 - 15:35	Oral Presentation from Abstract Submissions
15:35 - 15:50	Oral Presentation from Abstract Submissions
15:50 – 16:20	Coffee Break & Poster Viewing
16:20 – 18:10	SESSION 4: The Gut Microbiome, Physiology and Immunity
	Chair: Hans Stauss, UK
16:20 - 16:50	Keynote Lecture
	Structural modulation of gut microbiota and antigen load from the gut
	Liping Zhao, China
16:50 - 17:15	Microbiome, immunity  and  human disease
	Gregory F. Sonnenberg, USA
17:15 - 17:40	Microbiome remodelling leads to inhibition of intestinal farnesoid X receptor signalling and decreased obesity
	Frank J. Gonzalez, USA
17:40 - 17:55	Oral Presentation from Abstract Submissions
17:55 - 18:10	Oral Presentation from Abstract Submissions

 

Click HERE for the full scientific program.